CIK 0001162194 · Accelerated filer
STANDARD BIOTOOLS INC.
Sign in to watch- Ticker
- LAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770513190
- Phone
- 6502666000
- Business address
- 50 MILK STREET, 10TH FLOOR, BOSTON, MA, 02109
- Former names
- FLUIDIGM CORP
- Open-market buys, last 90 days
- $46,898
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$46,898. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Mackay Sean SVP & Chief Business Officer | Shares withheld for taxes | −25,729 | $1.00 | $26K | 1,006,552 |
| 2026-05-20 | Egholm Michael President & CEO | Shares withheld for taxes | −97,626 | $1.00 | $98K | 6,597,956 |
| 2026-04-06 | Egholm Michael President & CEO | Option exercise | +196,513 | 6,790,596 | ||
| 2026-04-06 | Egholm Michael President & CEO | Shares withheld for taxes | −95,014 | $0.91 | $86K | 6,695,582 |
| 2026-04-06 | Egholm Michael President & CEO | Option exercise · Restricted Stock Units | −196,513 | 0 | ||
| 2026-04-06 | Kim Hanjoon Alex Chief Financial Officer | Option exercise | +70,183 | 2,800,702 | ||
| 2026-04-06 | Kim Hanjoon Alex Chief Financial Officer | Shares withheld for taxes | −21,301 | $0.91 | $19K | 2,779,401 |
| 2026-04-06 | Kim Hanjoon Alex Chief Financial Officer | Option exercise · Restricted Stock Units | −70,183 | 0 | ||
| 2026-03-20 | Egholm Michael President & CEO | Grant or award | +1,042,373 | 6,594,083 | ||
| 2026-03-20 | Egholm Michael President & CEO | Grant or award · Stock Option (Right to buy) | +2,345,340 | 2,345,340 | ||
| 2026-03-20 | Mackay Sean SVP & Chief Business Officer | Grant or award | +272,107 | 1,032,281 | ||
| 2026-03-20 | Mackay Sean SVP & Chief Business Officer | Grant or award · Stock Option (Right to buy) | +612,240 | 612,240 | ||
| 2026-03-20 | Kim Hanjoon Alex Chief Financial Officer | Grant or award | +323,173 | 2,730,519 | ||
| 2026-03-20 | Kim Hanjoon Alex Chief Financial Officer | Grant or award · Stock Option (Right to buy) | +727,140 | 727,140 | ||
| 2026-02-26 | Casdin Eli Director | Grant or award | +52,991 | $1.17 | $62K | 2,954,053 |
| 2026-02-26 | Cox Troy Director | Grant or award | +57,264 | $1.17 | $67K | 376,586 |
| 2026-02-26 | Carey Thomas D. Director | Grant or award | +51,282 | $1.17 | $60K | 245,340 |
| 2026-02-23 | Egholm Michael President & CEO | Shares withheld for taxes | −66,127 | $1.15 | $76K | 5,551,710 |
| 2026-02-23 | Mackay Sean SVP & Chief Business Officer | Shares withheld for taxes | −19,661 | $1.15 | $23K | 760,174 |
| 2026-02-23 | Kim Hanjoon Alex Chief Financial Officer | Shares withheld for taxes | −12,740 | $1.15 | $15K | 2,407,346 |
Page 2 of 9 · 179 trades